Special Drug Use-results Survey for Long-term Use(Avacopan)

Recruiting Observational Study
Microscopic Polyangiitis (MPA) Granulomatosis With Polyangiitis (GPA)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
250 (estimated)
Sponsor
Kissei Pharmaceutical Co., Ltd. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan
Contacts

Kazunori Abe, director

0356843575

rinsyousiken@pharm.kissei.co.jp

CONTACT